Showing results (601-610 of 837) with videos related to
Sort By:
Pageof 84
Psychiatric Services (Washington, D.C.)|April 11, 2006
Use of emergency department services for somatic reasons by people with serious mental illnessAnn L Hackman, Richard W Goldberg, Clayton H Brown, et al.Iscience|May 2, 2022
Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometryXiyuan Lu, G Lavender Hackman, Achinto Saha, et al.Environment International|July 14, 2020
Fine particulate matter exposure during childhood relates to hemispheric-specific differences in brain structureDora Cserbik, Jiu-Chiuan Chen, Rob McConnell, et al.Blood|March 15, 1994
Retrovirus-mediated gene transduction into canine peripheral blood repopulating cellsH P Kiem, B Darovsky, C von Kalle, et al.The Journal of Clinical Investigation|November 13, 2013
Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppressionHelen Court, Marc Amoyel, Michael Hackman, et al.Iscience|March 14, 2023
Ambient fine particulate exposure and subcortical gray matter microarchitecture in 9- and 10-year-old children across the United StatesKirthana Sukumaran, Carlos Cardenas-Iniguez, Elisabeth Burnor, et al.Oral Oncology|August 25, 2023
Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemicJason Tasoulas, Travis P Schrank, Blaine D Smith, et al.Environment International|June 8, 2025
Fine particulate matter air pollution and longitudinal gray matter development changes during early adolescence: variation by neighborhood disadvantage levelAlethea V de Jesus, Hedyeh Ahmadi, Daniel A Hackman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomasJohn M Pagel, Christian Laugen, Lynn Bonham, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 16, 2014
Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unitMichelle L North, Terry J Walker, Lisa M Steacy, et al.Pageof 84